Literature DB >> 21228779

Serum levels of the Th1 chemoattractant interferon-gamma-inducible protein (IP) 10 are elevated in patients with essential hypertension.

Christian Stumpf1, Christoph Auer, Atilla Yilmaz, Piotr Lewczuk, Lutz Klinghammer, Markus Schneider, Werner G Daniel, Roland E Schmieder, Christoph D Garlichs.   

Abstract

Growing evidence shows that inflammation has a pivotal role in the pathophysiology of essential hypertension (EH). Although it has been acknowledged that target organ damage involves an inflammatory response, most work has focused on the role of macrophages, but T lymphocytes have recently become the center of interest. The goal of our study was to evaluate the role of T-cell-specific cytokines in the pathogenesis of EH. The study examined 39 patients with EH (57.7±6.8 years, systolic blood pressure (SBP) 157.5±11.8 mm Hg, diastolic blood pressure 92.2±12.9 mm Hg, mean arterial pressure 113.9±12.6 mm Hg) and 30 healthy, normotensive controls (55.2±4.9 years). Blood was drawn from a peripheral vein, and serum levels of interferon-inducible protein (IP)-10 and interleukins (IL)-4, -7 and -13 were measured by a multiplexing assay. Hypertensive patients had significantly higher levels of IP-10, IL-4, IL-7 and IL-13 than control subjects. When the patients were classified into tertiles according to their serum IP-10 levels (T1: 41.2-94.1 pg ml(-1); T2: 103.4-162.5 pg ml(-1); T3: 171.7-443.5 pgml(-1)), the patients classified into the highest tertile also had the highest blood pressure. In a correlation analysis, plasma IP-10 concentration was significantly associated with SBP (r=0.59, P<0.001). Furthermore, hypertensives with microalbuminuria, an early sign of hypertensive target organ damage, had the highest IP-10 levels. A stepwise multivariate regression analysis revealed IP-10 as the strongest independent predictor of SBP (P=0.01). In conclusion, our study provides new insights into the pathophysiological mechanisms in EH linking inflammation and IP-10. However, these preliminary results need to be confirmed in larger trials.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228779     DOI: 10.1038/hr.2010.258

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  16 in total

Review 1.  The role of chemokines in hypertension and consequent target organ damage.

Authors:  Nathan P Rudemiller; Steven D Crowley
Journal:  Pharmacol Res       Date:  2017-03-06       Impact factor: 7.658

Review 2.  Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management.

Authors:  Alexandra Jichitu; Simona Bungau; Ana Maria Alexandra Stanescu; Cosmin Mihai Vesa; Mirela Marioara Toma; Cristiana Bustea; Stela Iurciuc; Marius Rus; Nicolae Bacalbasa; Camelia Cristina Diaconu
Journal:  Diagnostics (Basel)       Date:  2021-04-12

Review 3.  Role of T lymphocytes in hypertension.

Authors:  Jiandong Zhang; Steven D Crowley
Journal:  Curr Opin Pharmacol       Date:  2014-12-15       Impact factor: 5.547

Review 4.  The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension.

Authors:  Revathy Carnagarin; Vance Matthews; Maria T K Zaldivia; Karlheinz Peter; Markus P Schlaich
Journal:  Br J Pharmacol       Date:  2018-09-25       Impact factor: 8.739

Review 5.  Evolution, Expression and Functional Analysis of CXCR3 in Neuronal and Cardiovascular Diseases: A Narrative Review.

Authors:  Devi Satarkar; Chinmoy Patra
Journal:  Front Cell Dev Biol       Date:  2022-06-20

6.  Mild hypercholesterolemia blunts the proinflammatory and prothrombotic effects of hypertension on the cerebral microcirculation.

Authors:  Stephen F Rodrigues; Shantel A Vital; D Neil Granger
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-02       Impact factor: 6.200

Review 7.  Autoimmunity: an underlying factor in the pathogenesis of hypertension.

Authors:  Keisa W Mathis; Hanna J Broome; Michael J Ryan
Journal:  Curr Hypertens Rep       Date:  2014-04       Impact factor: 5.369

Review 8.  Autoimmunity in the pathogenesis of hypertension.

Authors:  Bernardo Rodríguez-Iturbe; Héctor Pons; Yasmir Quiroz; Miguel A Lanaspa; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2013-11-19       Impact factor: 28.314

9.  Immunosuppression of Macrophages Underlies the Cardioprotective Effects of CST (Catestatin).

Authors:  Wei Ying; Kechun Tang; Ennio Avolio; Jan M Schilling; Teresa Pasqua; Matthew A Liu; Hongqiang Cheng; Hong Gao; Jing Zhang; Sumana Mahata; Myung S Ko; Gautam Bandyopadhyay; Soumita Das; David M Roth; Debashis Sahoo; Nicholas J G Webster; Farah Sheikh; Gourisankar Ghosh; Hemal H Patel; Pradipta Ghosh; Geert van den Bogaart; Sushil K Mahata
Journal:  Hypertension       Date:  2021-04-07       Impact factor: 10.190

10.  Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance.

Authors:  Matteo Martino; Giulio Rocchi; Andrea Escelsior; Michele Fornaro
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.